KEWAUNEE SCIENTIFIC CORP /DE/ KEQU
Nasdaq · XNAS · stock · Laboratory Apparatus & Furniture
Chart by TradingView
5/9
Piotroski F — financial health
4.75
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2026 | $282.0M | $9.6M | $80.4M | — | $74.7M |
| 2025 | $240.5M | $11.4M | $68.9M | — | $64.5M |
| 2024 | $203.8M | $18.8M | $52.1M | — | $54.8M |
| 2023 | $219.5M | $738,000 | $35.6M | — | $37.4M |
| 2022 | $168.9M | -$6.1M | $24.2M | — | $35.7M |
| 2021 | $147.5M | -$3.7M | $24.0M | — | $41.2M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Campbell John Jette | director | 2026-05-01 | Grant | 2,013 | — |
| GEHL KEITH M | director | 2026-05-01 | Grant | 2,013 | — |
| PYLE MARGARET B | director | 2026-03-26 | Gift | 2,750 | — |
| HULL THOMAS DAVID III | President, CEO | 2026-01-07 | Sell | 2,177 | $37.50 |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 4.75 (safe)
- Working capital / assets 0.32
- Retained earnings / assets 0.384
- EBIT / assets 0.094
- Equity / liabilities 0.736
Source: SEC EDGAR filings · CIK 0000055529 · as of 2026-04-30. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.